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Abstract To evaluate the possible contribution of Asp206 of
Trigonopsis variabilis D-amino acid oxidase (DAO) to its flavin
adenine dinucleotide (FAD) binding and catalytic function, six
mutant enzymes were constructed by site-directed mutagenesis.
Western immunoblot analysis revealed that a protein with an
apparent molecular mass of about 39.2 kDa was present in the
cell-free extracts of wild-type and mutant strains. Replacement
of Asp206 with Leu, Gly, and Asn resulted in the loss of DAO
activity and characteristic absorption spectrum for flavoenzyme,
while the other mutant DAOs, Asp206Glu, Asp206Ser, and
Asp206Ala, exhibited a similar spectral profile to that of wild-
type enzyme and retained about 6^90% of the enzyme activity.
These results suggested that Asp206 of T. variabilis DAO might
play an important role in the binding of FAD.
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1. Introduction
D-Amino acid oxidase (DAO, EC 1.4.3.3) is a £avoenzyme
that catalyzes the oxidation of D-amino acids to their corre-
sponding keto acids [1]. The oxidative reaction is coupled to
the reduction of an obligatory £avin adenine dinucleotide
(FAD) cofactor and the reduced prosthetic group is reoxi-
dized by molecular oxygen with the release of hydrogen per-
oxide [2]. The enzyme shows an ubiquitous distribution
among eukaryotic cells ranging from yeasts to mammals [3^
8]. In addition, DAO activity has been found in prokaryotes
[9^11] despite the lack of its physiological signi¢cance. The
detection of signi¢cant quantities of D-amino acids in various
mammalian tissues suggests that DAO is not a vestigial en-
zyme [8].
Trigonopsis variabilis DAO is a dimeric enzyme that con-
sists of two identical subunits and needs one FAD molecule
per subunit for its function [12]. To date, the nucleotide se-
quences of cDNA encoding DAO have been determined in T.
variabilis [13], Fusarium solani [14], Rhodotorula gracilis [15],
Rhodotorula toruloides [16] and a variety of animal cells [17^
20]. Sequence analysis of DAOs reveals that there are six
conserved regions (designated as regions I, II, III, IV, V and
VI) among the DAOs and regions I and III are indicated to be
essential for FAD binding [15]. In the present study, the in-
teraction between an aspartate residue in region II of T. va-
riabilis DAO and the coenzyme FAD was investigated by site-
directed mutagenesis.
2. Materials and methods
2.1. Strains, vectors, media and reagents
T. variabilis CCRC 21509 was obtained from the Culture Collection
and Research Center, Hsinchu, Taiwan. Escherichia coli strains used
were JM109 [21], CJ236 [22] and MV1190 [21]. The vectors used were
pQE30 (Qiagen, CA, USA) and M13mp19 (Bio-Rad, CA, USA).
Yeast was grown in a YCBA medium (0.67% yeast carbon base and
0.2% D,L-alanine) at 30‡C with shaking at 150 rpm on a rotary shaker.
Recombinant E. coli strains were cultivated at 37‡C in Luria-Bertani
(LB) broth containing 100 Wg/ml ampicillin. Oligonucleotides (Table
1) were obtained from Quality Systems (Taipei, Taiwan). Restriction
enzymes were purchased from Boehringer Mannheim (Mannheim,
Germany) and Promega (WI, USA). Deep Vent DNA polymerase
was obtained from New England Biolabs (MA, USA). All other
chemicals were of the highest purity available.
2.2. Recombinant DNA methods
DNA isolation, agarose gel electrophoresis and transformation of
E. coli were carried out as described by Sambrook et al. [23]. Restric-
tion endonucleases and other DNA modifying enzymes were used in
accordance with the manufacturers’ instructions. DNA sequencing
was performed by the dideoxy method [24] with a Sequenase R ver-
sion 2 sequencing kit (United States Biochemical, OH, USA).
2.3. Construction of expression plasmid
T. variabilis was cultivated in 1000 ml of YCBA medium for 24 h.
Cells were harvested by centrifugation and homogenized with 2 g of
glass beads in 25 mM sodium citrate bu¡er (pH 7.0) containing 4 M
guanidium thiocyanate and 0.5% N-lauroyl sarcosine. The total RNA
was isolated from the cell extract according to the method of Loge-
mann et al. [25]. The dao cDNA was prepared from poly(A) RNA
with a SuperScript Preampli¢cation kit (BRL, MD, USA) followed by
a PCR ampli¢cation. PCR mixtures (100 Wl) contained 20 Wl of cDNA
sample, 200 WM of each deoxynucleotide triphosphate, 10 Wl of a 10U
reaction bu¡er (New England Biolabs, MA, USA), 10 pmol of each
primer and 0.5 U of Deep Vent DNA polymerase (New England
Biolabs). Samples were ampli¢ed with a DNA thermal cycler (model
9600; Perkin-Elmer, CO, USA) under the following conditions: initial
denaturation at 94‡C for 1.5 min, followed by 30 cycles of denatura-
tion at 94‡C for 3 min, annealing at 55‡C for 1 min and extension at
74‡C for 2 min. The PCR product was digested with BamHI and
HindIII and subcloned into the corresponding sites of pET21b or
pQE30 vectors to generate pET21b-DAO and pQE30-DAO, respec-
tively.
2.4. Puri¢cation of the recombinant proteins
A single colony from LB plate was inoculated in 100 ml of LB
medium containing 100 Wg/ml ampicillin in 500-ml £asks. Cells were
grown at 28‡C until OD600 was 1.0. Isopropyl-L-D-thiogalactopyrano-
side (IPTG) was then added to a ¢nal concentration of 1 mM and the
cultivation was continued for 5 h. The cells were harvested by centri-
fugation at 9000Ug for 10 min and the pellets were washed once with
binding bu¡er (5 mM imidazole, 0.5 M NaCl and 20 mM Tris-HCl;
pH 7.9), resuspended in 3 ml of the above bu¡er and disrupted by
sonication. Cell debris was removed by centrifugation (12 000Ug) and
the resulting extracts were used for protein puri¢cation. Plasmid
pQE30-DAO has an IPTG-regulated T5 promoter, followed by the
multiple cloning sites with a six-histidine tag. Under the induction of
IPTG, the six-histidine tag and the inserted gene were expressed as a
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fusion protein and it could be puri¢ed by a⁄nity chromatography
with HisWBind resin (Novagen, WI, USA).
2.5. Site-directed mutagenesis
For site-directed mutagenesis, the dao gene on a BamHI-HindIII
fragment from pQE30-DAO was cloned into phage M13mp19 to gen-
erate pM19-DAO. The uridinylated DNA template of pM19-DAO
was prepared in E. coli CJ236 and oligonucleotide-directed mutagen-
esis was performed according to Kunkel [26] using the ‘Muta-Gene
M13 in vitro Mutagenesis’ kit from Bio-Rad. E. coli MV1190 was
used as the recipient strain for in vivo screening of the transformants
on glucose-minimal medium. Single-stranded DNA from the mutant
clones was prepared and subjected to dideoxy sequencing to con¢rm
the successful mutations.
2.6. Enzyme assay
DAO activity was measured spectrophotometrically according to
the procedure described by Lee et al. [27]. One unit of DAO activity
was de¢ned as the amount of enzyme releasing 1 nmol of pyruvate
equivalent per min. Speci¢c activity is expressed as units per milligram
of protein. Protein content was estimated by the method of Bradford
[28] and bovine serum albumin was used as a standard. The Km
(Michaelis constant) and kcat (number of substrate molecules trans-
formed per second per molecule of enzyme) values for DAO were
estimated from Lineweaver-Burk plots.
2.7. Electrophoresis and immunobloting
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) was performed essentially as described by Laemmli [29]. Pro-
teins were electrophoretically transferred to Immobilon-P transfer
membrane (Millipore, MA, USA) from SDS-PAGE in a Bio-Rad
Transblot Cell with a transfer bu¡er containing 25 mM Tris-HCl
(pH 8.3), 192 mM glycine and 20% methanol. The proteins were
detected on Immobilon-P membrane with polyclonal anti-DAO anti-
body and alkaline phosphatase-conjugated antibody. Non-fat milk
powder (5%) in Tris-bu¡ered saline was used as a blocking agent.
3. Results and discussion
For the expression of T. variabilis dao gene, oligonucleo-
tides DAO-1 and DAO-2 (Table 1) were used for gene-speci¢c
ampli¢cation of double-stranded dao cDNA. The ampli¢ed
fragment was cloned downstream from the IPTG-inducible
T7 promoter of plasmid pET21b to give plasmid pET21b-
DAO. E. coli BL21(DE3) harboring pET21b-DAO was as-
sayed for DAO activity. A very low level of enzyme activity
was detected in the extract of IPTG-induced transformant.
This low level of expression for DAO was thought to result
from the formation of large amounts of inclusion bodies in E.
coli (data not shown). Alternatively, the PCR-ampli¢ed frag-
ment was cloned into BamHI and HindIII sites of pQE30 to
obtain pQE30-DAO. The constructed plasmid was trans-
formed into E. coli JM109. Transformants were randomly
picked for sequence con¢rmation of the dao gene in the plas-
mids and one transformant was chosen for expression analy-
sis. When crude extracts from strain JM109 harboring
pQE30-DAO were analyzed by SDS-PAGE, a protein band
exhibiting an apparent molecular mass of 39.2 kDa was de-
tected (Fig. 1A). Western blot analysis con¢rmed the presence
of the recombinant DAO in the E. coli crude extracts (Fig.
1B). These results suggested that the translation of dao gene
was assumed to be initiating at the correct AUG codon. A
DAO speci¢c activity of 18.61 U/mg was obtained in the
crude extract of E. coli JM109 harboring pQE30-DAO (Table
2).
Random mutagenesis of the dao gene was performed using
the procedure of Cadwell and Joyce [30]. Of the transform-
ants, one mutant enzyme was found to display a rather strik-
ing change in the absorbance spectrum as compared with that
of the wild-type enzyme. Sequence analysis of the mutant gene
revealed that double changes (AEG and CET) occurred at
positions 652 and 653, respectively, of the dao gene, indicating
the replacement of Asp206 with Gly. In order to assess the role
of Asp206 in T. variabilis DAO, six site-directed mutants were
constructed: Asp206Ala, Asp206Leu, Asp206Gly, Asp206Glu,
Asp206Asn and Asp206Ser. Expression of the six DAO mutants
was detected by Western blotting (Fig. 1B). Speci¢c activity
was determined to be 16.71 U/mg for Asp206Glu and 6.41 U/
mg for Asp206Ser (Table 2). Less than 6% of the speci¢c ac-
tivity was retained for the other mutant DAOs. These results
suggested that Asp206 plays an essential role for the DAO
activity. The kinetic parameters Km and kcat obtained with
Asp206Ala, Asp206Glu and Asp206Ser are given in Table 2.
As compared with the wild-type DAO, those mutations
caused 2^4.4-fold increase in Km and 59^97% decrease in
kcat values. The values of kcat/Km for Asp206Glu, Asp206Ala,
and Asp206Ser are about 6/1000^1/5th of that of the wild-type
enzyme, indicating that substitution of amino acid residue at
position 206 signi¢cantly in£uences the DAO-substrate inter-
action.
Spectral analysis is one of the well-known approaches for
the observation of FAD-dependent enzymes [31^33]. In order
to obtain information about the DAO-bound FAD, the spec-
tral properties of the wild-type and mutant enzymes were in-
vestigated (Fig. 2). The wild-type DAO exhibited a typical
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Table 1
Oligonucleotide primers used in this study
Primer for Sequence
PCR
DAO-1 5P-GCTGGATCCATGGCTAAAATCGTTGTTATTGG-3P
BamHI
DAO-2 5P-CATAAGCTTCTAAAGGTTTGGACGAGTAAGAG-3P
HindIII
Site-directed mutagenesis
Asp206Ala 5P-AGGCGTCGAGGCCAAGAAGA-3P
Asp206Glu 5P-AGGCGTCGAGGAAAAGAAGA-3P
Asp206Leu 5P-AGGCGTCGAGCTGAAGAAGA-3P
Asp206Asn 5P-AGGCGTCGAGAACAAGAAGA-3P
Asp206Gly 5P-AGGCGTCGAGGGTAAGAAGA-3P
Asp206Ser 5P-AGGCGTCGAGTCCAAGAAGA-3P
Fig. 1. SDS-PAGE (A) and Western blot (B) analyses of the wild-
type and mutant DAOs. A: Lane 1: protein size marker; lane 2:
total proteins prepared from E. coli JM109 (pQE30-DAO) without
IPTG induction; lane 3: total proteins prepared from E. coli JM109
(pQE30-DAO) with IPTG induction. B: Lane 1: wild-type DAO;
lane 2: Asp206Ala; lane 3: Asp206Glu; lane 4: Asp206Leu.
S.-S. Ju et al./FEBS Letters 436 (1998) 119^122120
absorption spectrum of £avoprotein with two peaks at 380
and 450 nm as that of the free FAD. Asp206Glu displayed a
similar spectral pro¢le to that of the wild-type enzyme.
Although the spectra of Asp206Ala and Asp206Ser still exhib-
ited two absorption peaks as that of the wild-type enzyme, the
absorbance at 380 and 450 nm was greatly reduced. For the
three other mutants (Asp206Gly, Asp206Leu and Asp206Asn),
the FAD-dependent peaks disappeared in the absorbance
spectra. These results indicated that the incorrect interaction
between the mutant enzymes and FAD could signi¢cantly
decrease the attachment of FAD to apoenzyme, which led
to a defect in the catalytic function of DAO.
Aspartate residues are often found on the surface of glob-
ular proteins or are partially buried with the hydroxyl group
available for intermolecular hydrogen bonding [34]. It is noted
that Asp206 of T. variabilis DAO in region II is highly con-
served among di¡erent DAOs (Fig. 3). Examples of aspartate
that play a role in catalytic activity can be illustrated by gly-
colate oxidase in which it is postulated to contribute a part of
charge in positioning the lysine residue close the N(1)^
C(2)NO locus of the £avin through a water molecule [35].
Another example is that the oxygen atoms in the side chain
of Asp35 of sarcosine oxidase and Glu33 of lipoamide dehy-
drogenase could both interact with the ribose ring of FAD
and form two hydrogen bonds [33,36]. The loss of the FAD
characteristic spectra of the three DAO mutants (Asp206Asn,
Asp206Leu and Asp206Gly) indicated that the oxygen atom in
the carboxyl group of the Asp206 side chain was required for
FAD-apoenzyme binding. As shown in Fig. 2, Asp206Glu had
a similar absorption spectrum for £avoenzyme as that of wild-
type DAO. Since the side chains of Asp and Glu di¡er by one
methylene group, the results further supported that the car-
boxyl group of amino acid residue is involved in FAD bind-
ing. About 34% of the DAO activity was retained in
Asp206Ser and the mutant enzyme showed a decrease in
absorbance intensity for £avoenzyme. The results implicated
that the hydroxyl group of serine residue is less likely to
interact with FAD as compared with the carboxyl group of
aspartate residue. The Asp206Ala enzyme had detectable but
extremely low speci¢c activity (1.04 U/mg of protein), which
was only 5.6% of the speci¢c activity for the unaltered DAO.
The small amount of activity recorded for the Asp206Ala en-
zyme is unexplained; however, it is possible that replacement
with alanine may have increased the accessibility of FAD to
other residues, which provided hydrogen bonds in place of
Asp206.
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Fig. 2. Spectral pro¢les of free FAD, wild-type and mutant DAOs.
FAD and enzymes were dissolved in 20 mM Tris-HCl bu¡er (pH
7.9) and approximately 0.1 mg of enzyme per ml was used for anal-
ysis. Spectrophotometric analysis was done with a Beckman DU
600 at wavelength ranging from 300 to 500 nm.
Fig. 3. The proposed FAD-binding domains of DAOs. Amino acid
residues are indicated by single letters. Conserved amino acid resi-
dues are in gray boxes. Tri: Trigonopsis variabilis DAO; Rho: Rho-
dotorula gracilis DAO; Fus: Fusarium solanii DAO; Pig: pig DAO;
Hum: human DAO; Rab: rabbit DAO; Mou: mouse DAO.
Table 2
Catalytic properties of wild-type and mutant DAOs
Enzyme Speci¢c activities (U/mg) kcat (min31) Km (mM) kcat/Km (min31 mM31)
Wild type 18.61 0.34 4.63 73.43
Asp206Glu 16.71 0.14 9.36 14.95
Asp206Ser 6.41 0.06 20.52 2.92
Asp206Ala 1.04 0.01 18.12 0.44
Asp206Gly 0.00 ^a ^ ^
Asp206Leu 0.00 ^ ^ ^
Asp206Asn 0.00 ^ ^ ^
a^, Not determined.
S.-S. Ju et al./FEBS Letters 436 (1998) 119^122 121
Taken together, these results suggested that the oxygen
atom in the carboxyl group of the Asp206 side chain was in-
volved in FAD-apoenzyme binding. Although the three-di-
mensional structure of T. variabilis DAO is not known, a
homologous protein, pig kidney DAO, has been determined
[2]. Sequence alignment of these two DAOs indicates that this
speci¢c aspartate residue corresponds to Asp192 of pig kidney
DAO, which is located on a loop 190^195 between an K-helix
(KF4) and a L-strand (L14) (Fig. 4). Based on this structure, it
is not likely that Asp192 can directly participate in binding
with FAD. Instead, the hydroxyl group of Tyr309 in a loop
309^311 and the guanidinyl group of Arg286 in another loop
286^289 are in close proximity to the oxygen atoms of the
Asp192 residue. Firm interactions between Asp192 and these
two residues may possibly take place and thus yield a stable
conformation essential for FAD binding. Indeed, His311, one
of the proposed residues involved in FAD binding, is found
on the loop 309^311. Since T. variabilis DAO is homologous
to pig kidney DAO and since all these three residues (Asp192,
Arg286 and Tyr309 of pig kidney DAO) are well conserved
among di¡erent DAOs, it is speculated that Asp206 of T. va-
riabilis DAO may play a similar role as that of Asp192 of pig
kidney DAO.
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Fig. 4. RasMol diagram of the FAD binding cavity and Asp192 in
the pig kidney DAO crystal structure.
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